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Abstract
In male Wistar rats, behavioral and electrophysiological investigations, and blood and brain manganese level determinations, were performed;
during 10 weeks treatment with low-dose manganese chloride and a 12 weeks post-treatment period. Three groups of 16 animals each received
daily doses of 14.84 and 59.36 mg/kg b.w. MnCl2 (control: distilled water) via gavage. During treatment period, Mn accumulation was seen
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drst in the blood, then in the brain samples of the high-dose animals. Short- and long-term spatial memory performance of the treated animals
ecreased, spontaneous open field activity (OF) was reduced. The number of acoustic startle responses (ASR), and the pre-pulse inhibition
PPI) of these, diminished. In the cortical and hippocampal spontaneous activity, power spectrum was shifted to higher frequencies. The
atency of the sensory evoked potentials increased, and their duration, decreased. By the end of the post-treatment period, Mn levels returned
o the control in all samples. The impairment of long-term spatial memory remained, as did the number of acoustic startle responses. Pre-pulse
nhibition, however, returned to the pre-treatment levels. The changes of the open field activity disappeared but a residual effect could be
evealed by administration of d-amphetamine. The electrophysiological effects were partially reversed.
By applying a complex set of methods, it was possible to obtain new data for a better-based relationship between the known effects of Mn
t neuronal level and the behavioral and electrophysiological outcomes of Mn exposure.
2005 Elsevier B.V. All rights reserved.
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. Introduction
Manganese (Mn) is, in small amounts, an essential
icronutrient (WHO, 1981), being cofactor in metallo-
nzymes. In prolonged exposure to higher doses it is, how-
ver, a potential environmental neurotoxicant. In the general
opulation, excess dietary intake (beyond the estimated safe
nd adequate daily amount) is more typical, as in case of ba-
ies fed by cow milk or soybean-based formulas (Marlowe
nd Bliss, 1993), or in the population having environmental
xposure via the drinking water. In Greece, 50 mg/l Mn in
he drinking water was associated with neurological effects
Kondakis et al., 1989). Mn as man-made environmental con-
∗ Corresponding author. Tel.: +36 62 545 119; fax: +36 62 545 120.
E-mail address: vezer@puhe.szote.u-szeged.hu (T. Veze´r).
taminant originates from Mn-containing waste (e.g. batter-
ies), methylcyclopentadienyl manganese tricarbonyl (MMT)
used as anti-knock petrol additive, and organo-Mn agricul-
tural fungicides (ATSDR, 2000).
Following ingestion, inorganic Mn is absorbed in the in-
testine mostly in trivalent form (Cotzias et al., 1971) in a
homeostatic self-limiting process. The main sites of depo-
sition are the mitochondria-rich tissues, e.g. liver, pancreas,
pituitary gland and the muscles (Barceloux, 1999). Brain is
among the primary target organs in chronic Mn exposure
(Roels et al., 1987), and the turnover of Mn there is much
slower than in other parts of the body (Feldman, 1992).
In subchronic dosage, Mn appears in the cerebral and cere-
bellar cortex (Dorman et al., 2000). In case of chronic intake,
Mn is found in motor control centers such as the basal ganglia,
particularly the globus pallidus, striatum and substantia ni-
382-6689/$ – see front matter © 2005 Elsevier B.V. All rights reserved.
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gra where it causes degeneration (Yamada et al., 1986). Mn
accumulation was also described in the pons and medulla
(Chan et al., 1992), and in the hippocampus (Takeda et al.,
1998).
The high sensitivity of different behavior types and the
integration of different (motor, sensory, attentional, motiva-
tional) behavioral functions is especially important in assess-
ment neurotoxic risk due, e.g. to Mn. Excess Mn was shown
to cause several neurotoxic effects such as childhood hyper-
activity disorder (Barlow, 1983), manganese psychosis, ex-
trapyramidal dysfunction (Quaghebeur et al., 1996), motor
deficit (above 7.5g/l blood Mn; Mergler et al., 1999); as well
as altered childhood psychomotor development (Takser et al.,
2003) and impairments of several memory process (list learn-
ing, visual recognition, digit span). Lucchini et al. (1999)
found irritability and motor functional damage in exposed
workers having ca. 10g/l blood Mn level. A child devel-
oped severe epilepsy following exposure to welding fumes
resulting in 15–20g/l blood Mn (Hernandez et al., 2003).
Similar deficits were also induced by Mn in animals. ¨Oner
and Sentu¨rk (1992) saw impaired T-maze learning in rats re-
ceiving 375g/kg b.w. Mn for 30 days. Ingersoll et al. (1995)
elicited spontaneous hypoactivity by intrathecal administra-
tion of MnCl2. Dorman et al. (2000) described altered acous-
tic startle responses (ASR) in neonatal rats receiving 25 and
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There has been ample literature on the negative effects
of MnCl2 on behavioral outcomes in rats. Several mecha-
nisms have been purposed, such as influence on transmitter
systems (Tran et al., 2002; Gwiazda et al., 2002), or directly
on structural elements like hippocampal astrocytes (Aschner,
1996) and the midbrain and basal ganglia (Erikson and
Aschner, 2002). The dentate gyrus (primarily the granule
cells) plays an important role in the acquisition of new infor-
mation (Ogura et al., 2002) and is possibly neural substrate
of spatial reference and working memory, and of synaptic
plasticity (Ikegaya et al., 1995). Agents acting on the dentate
gyrus possibly affect learning and memory performance, lo-
comotor activity, radial maze performance and spontaneous
motor activity, and psychomotor performance.
In the works cited above, however, behavioral effects were
not supported by histochemical or electrophysiological find-
ings, and no follow-up in the after-exposure period was in-
cluded. The electrophysiological effect of Mn exposure is in
itself an open question: some authors found disturbances of
spontaneous or stimulus-evoked cortical activity in workers
exposed to comparable airborne Mn levels (Sinczuk-Walczak
et al., 2001) while others did not (Deschamps et al., 2001).
Hence, our experiment involved a complex behavioral test
battery (8-arm radial maze, open field activity—OF, acous-
tic startle response—ASR, and pre-pulse inhibition—PPI).
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Significant relationship between neurotoxic alterations,
eurotransmitter or modulator metabolism (first of all cat-
cholamines), and Mn exposure have been described (Neff
t al., 1969). Mn, in case of prolonged low level ex-
osure, accumulates in the nigrostrial dopaminergic path-
ay (Subhash and Padmashree, 1991). The resulting
opaminergic–glutamatergic interactions are involved in the
n effects on extrapyramidal motor functions and, indirectly,
n the sensorimotor integration (Calabresi et al., 1997).
Direct toxicity of Mn to dopaminergic neurons was de-
cribed by Parenti et al. (1987). The involvement of other
ransmitters can result from dopaminergic control upon these
Takeda et al., 2002) or by direct effect of Mn. The lat-
er is know to exist in the GABAergic (Trepper et al.,
998) and glutamatergic system. Reduced glial glutamate
ptake (Aschner et al., 1999) leads, as a direct result of
mpaired astrocytic-neuronal interactions (Hazell, 2002), to
ncreased extracellular glutamate concentration, the excito-
oxic effect of which could play a key role in manganese-
nduced neuronal cell death. Marked reactive astrocytosis,
ith significant hypertrophy of glial fibrillary acid protein-
mmunoreactive—GFAP-IR—astrocytes, was seen on Mn
xposure in the globus pallidus (Baeck et al., 2003). In the
ippocampal dentate gyrus, Mn exposure caused a decrease
f GFAP-IR area in juvenile, but an increase in adult, rats
Pappas et al., 1997). This, together with the numerous ef-
ects of Mn exposure on the behavior, raised the possibility
hat these functional and morphological changes induced by
n develop in parallel and are in detectable causal relation-
hip.ur behavioral investigations were supplemented by corti-
al electrophysiology (electrocorticogram—ECoG, evoked
otentials—EP), immunhistochemistry (GFAP in various
arts of the hippocampus), and by Mn level determination
n blood, cortex and hippocampus. All investigations were
erformed both during and after the period of Mn adminis-
ration. It was also attempted to prove the involvement of the
opamine (DA) system by applying a dopaminergic agonist
n the elimination period.
. Methods
.1. Animals, housing, treatment
Young adult male Wistar rats (220–250 g body weight
t start), obtained at the University’s Breeding Center, were
sed. The animals were housed under controlled conditions
f temperature (22–24 ◦C) and photoperiod (12-h light:12-h
ark cycle with light starting at 06:00 h), with free access to
rinking water. Three weeks before starting the treatment,
he animals (up to 4 rats per cage) were put in cages of
8 cm× 40 cm× 20 cm. The memory test used required that
uring the 10 weeks of treatment the animals had a restricted
ccess to food (1 h/day) resulting in a mild (ca. 20–25%)
ody weight loss (Beatty and Shavalia, 1982). Body weight
as measured and the animals’ general state was observed
very day.
The rats were divided into three groups, consisting of
6 animals each at start. One group was treated with 14.84
low dose group), and another one with 59.36 (high dose
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group), mg/kg b.w. inorganic Mn (MnCl2·4H2O, minimum
99% purity, REANAL Hungary) dissolved in distilled water
to 1 ml/kg administration volume, given by gavage, 5 days
a week, for 10 weeks (Table 1). These doses were 1/100
and 1/25 of the acute oral rat-LD50, taken from the safety
data for manganese(II) chloride tetrahydrate (Physical and
Theoretical Chemistry Laboratory, 2001). (Our own LD50
determination gave a similar value. Literature with compara-
ble figures, referred to in Section 1, indicated that this dose
range is likely to cause behavioral alterations.) Animals in
the third (control) group received distilled water.
The whole study was done in adherence to the require-
ments by the Ethical Committee for the Protection of Animals
of the University.
2.2. Time scheme of the tests performed
The time scheme of the whole experiment, and the number
of animals used, is summarized in Table 1. The experiment
lasted 22 weeks, whereby the 0th week was pre-treatment
period, the treatment period involved the 1st to 10th weeks,
and the 11th to 22nd weeks constituted the post-treatment
period.
The spatial maze learning and memory test were done
throughout the whole treatment period. In the 0th, 5th and
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Table 1), with one training per day, the rats learned to visit the
farthest points of each arm. This way, the rats were forced to
acquire a win-shift food-rewarded learning strategy (Beatty
and Shavalia, 1982). The rate of correct responses was given
in percents. (Incorrect responses consisted of revisiting an
arm previously visited in the same session.) All animals had
a run performance of over 85%. Based on this memory con-
tent, the following tests were performed:
Short term spatial workingmemory testswere done in the 3rd
and 5th treatment week (Mem 2h and Mem 4h; Table 1). The
rats were one by one put for 10 min maximum in the center of
the maze, but were allowed to enter only four of the eight open
and baited arms (at their own random selection); this was the
“event-to-be-remembered”. After visiting the four arms, the
animal was returned to its cage and kept there for 2 or 4 h.
The rat was then put again in the maze center and allowed
to complete arm choices 5–8 to obtain rewards in the four
baited arms not visited before. In the working memory tests,
errors (WM error) meant reentry into any of the baited arms
visited in the first run. Working memory performance was
thus counted as [(correct responses−WM errors)× 100].
Reference memory was tested in the 4th week with 16 rats
per group. Here, food reward was put only in the four arms
preferred by the individual rats. Entering an unbaited arm
constituted a reference memory error, from which perfor-
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b0th week, a subset of 12 per group was tested for loco-
otor activity, and in the 5th and 10th week, for acoustic
tartle response. In the 5th week, three rats per group under-
ent electrophysiological recording, and were sacrificed for
lood and tissue sampling to determine Mn content (blood
amples were also taken in the 0th week). In the 10th week,
ve animals per group were used for electrophysiological
ecording and sacrificed for blood and tissue sampling; and
nother two per group were sacrificed for GFAP histochem-
stry (see Section 2.4). The remaining six animals per group
ere kept for further 12 weeks, during which spatial memory,
ocomotor activity and acoustic startle tests were repeated to
ee any elimination of Mn and disappearance of its effects.
inally, electrophysiological recording, and blood and tissue
ampling, was done on these animals.
.3. Behavioral tests
The maze and open field tests were done between 08:00
nd 14:00 h, in a room of low illumination and noise level,
ifferent from that used for keeping and treating the animals.
coustic startle response and pre-pulse inhibition test were
erformed under identical conditions later in the day.
.3.1. Test procedure for spatial learning and memory
The animals’ spatial learning ability was tested in an 8-
rm radial maze (Columbus Instruments, Ohio, USA). In the
st week of treatment period (Table 1), the animals had 10-
in training sessions twice a day whereby they were (under
artial food deprivation, see above) adapted to find food pel-
ets in the maze arm ends. During acquisition (Acquisition inance was calculated as above.
est periods, lasting 2 weeks, were introduced twice: in the
th to 7th treatment weeks and in the 1st to 2nd post-treatment
eeks. In these times, the animals were kept in the housing
oom, did not have any testing, and were not exposed to new
nformation.
ong-termworkingmemory (retention) testswere done in the
th to 10th treatment, and 3rd to 5th post-treatment weeks.
n the 8th week, memory return was observed, and in the
th and 10th week, 2- and 4-h working memory (Mem R 2h
nd Mem R 4h; Table 1). This sequence was repeated in the
ost-treatment period (Returm(e),Mem(e)R 2h,Mem(e)R 4h;
able 1).
.3.2. Locomotor activity
The rats’ spontaneous motor behavior was assessed, us-
ng a fixed subset of 12 rats from each group, in the 0th,
th and 10th week of treatment phase, and, with six rats
of the 12 tested previously) per group, in the 7th post-
reatment week (Table 1). The test was performed always
nce in the given weeks, following the maze-learning ses-
ion. The animals were first allowed to accommodate in
he testing room for 30–40 min. An open field (OF) box
f 40 cm× 40 cm× 40 cm size (ACTIFRAME, Gerb Elec-
ronic, Berlin, Germany), equipped with two arrays (at 3 and
5 cm above floor level) of infrared movement detectors with
.1 cm distance between the beams, was used. Illumination
t the floor of the OF was 12–25 lx, with ca. 40 dB white
ackground noise. The animals were placed into the center
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Table 1
Time scheme of experiment (lasting from the 0th to the 22nd weeks)—the pre-treatment week and treatment (A) and post-treatment (B) period
Investigations Pre-treatment
week
Weeks of theMnCl2-treatment period (1st to 10th experimental weeks)
0th 1st 2nd 3rd 4th 5th 6th 7th 8th 9th 10th
(A)
Learning and memory tests – Adaptation
(3× 16)
Acquisition
(3× 16)
Mem 2h
(3× 16)
Reference
(3× 16)
Mem 4h
(3× 16)
Rest
(3× 13)
Rest
(3× 13)
Return
(3× 13)
Mem R 2h
(3× 13)
Mem R 4h
(3× 13)
Open field (3× 12) – – – – (3× 12) – – – – (3× 12)
ASR/PPI – – – – – – – – – – (3× 12)
Electrophysiology – – – – – ECoG, EP
(3× 3)
– – – – ECoG, EP
(3× 5)
Histology – – – – – – – – – – (3× 2)
Mn content in: blood (3× 3) – – – – Blood, cortex,
hippoc. (3× 3)
– – – – Blood, cortex,
hippoc. (3× 5)
Investigations Weeks of the post-treatment (elimination) period (11th to 22nd experimental weeks)
1st 2nd 3rd 4th 5th 6th 7th 8th 9th 10th 11th 12th
(B)
Learning and memory tests Rest(e)
(3× 6)
Rest(e)
(3× 6)
Return(e)
(3× 6)
Mem(e)R 2h
(3× 6)
Mem(e)R 4h
(3× 6)
– – – – – – –
Open field – – – – – (3× 6) 0.5 d-A (3× 6) – 1.5 d-A (3× 6) – –
ASR/PPI 6) – – – – –
Electrophysiology – – – – ECoG, EP
(3× 6)
Mn content in: – – – – Blood, cortex,
hippoc. (3× 6)
Tests and investigations p , low dose and control) investigated, the number in the cells show the number of
animals used in the differ , 2-h working memory after first return; Mem R 4h, 4-h working memory after first
return; ASR/PPI, acousti ppocampus. (B) Rest(e), resting weeks in the post-treatment (elimination) period;
Return(e), second memor rn; Mem(e)R 2h, 2-h working memory after second return; d-A, d-amphetamine.– – – – – (3×
– – – – – –
– – – – – –
erformed are indicated in the column of the corresponding week. There were three groups (high dose
ent tests. Abbreviations: (A) Mem 2h, 2-h working memory; Mem 4h, 4-h working memory; Mem R 2h
c startle response and pre-pulse inhibition; ECoG, electrocorticogram; EP, evoked potential; hippoc., hi
y return in the post-treatment (elimination) period; Mem(e)R 2h, 2-h working memory after second retu
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of the box and their spontaneous horizontal (running), ver-
tical (rearing) and local (predominantly grooming) activity
was scored during a 10 min session. Movement scores were
computed on the basis of beam interruptions with a PC soft-
ware having preset conditions to discriminate between forms
of movement.
2.3.3. Amphetamine-induced locomotor activity
d-Amphetamine (d-A) is known to pass the blood–brain
barrier and increase the release of catecholamines (including
DA) from presynaptic endings (Clarkson et al., 1988). On the
8th and 10th post-treatment week, the same rats tested before
in the open field were i.p. injected with 0.5 or 1.5 mg/kg b.w.
of d-A, respectively (Table 1). Fifteen minutes later, their OF
activity was recorded again.
2.3.4. Acoustic startle response and pre-pulse inhibition
The ASR and PPI test was performed on the same an-
imals as the OF test, in the 10th treatment and 7th post-
treatment week (Table 1). In this test of sensorimotor con-
trol and gating (Feifel et al., 1999), whole body muscle
twitch as a response to a sudden acoustic stimulus is mea-
sured. A commercially available reflex monitor (Respon-
der X System, Columbus Instruments, Ohio, USA) was
used. The animals were, one by one, put in the plexiglass
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Then, the surface electrodes were used to record corti-
cal evoked potentials. For somatosensory stimulation, a pair
of needles was inserted into the area of the whiskers and
rectangular stimuli (1 Hz, 3–4 V, 0.2 ms) were applied. Vi-
sual stimulation was performed by flashes (1 Hz, 60 lx) de-
livered by a flashbulb via an optical fiber directly into the
contralateral eye of the rat. For acoustic stimulation, clicks
(1 Hz, 40 dB), from a small earphone were applied into the
contralateral ear of the rat. Fifty stimuli of each modality
per rat were applied and the EPs recorded. After averag-
ing, latency and duration of the main waves was measured
manually.
All recording of spontaneous and evoked activity and off-
line analysis was performed by a PC using the NEUROSYS
1.11 software (Experimetria Ltd., UK).
2.5. Immunohistochemistry
After finishing behavioral tests in the 10th treatment week,
two rats per group (Table 1), were brought to terminal Nem-
butal anesthesia and were perfused transcardially first with
50 ml physiological saline (pre-rinse) then with 400 ml 4%
paraformaldehyde fixative solved in 0.1 M phosphate buffer
(PB, pH 7.4). The brains were removed from the skull, post-
fixed for 4 h and cryoprotected by overnight storage in 30%
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eest cage (16 cm× 28 cm× 18 cm) the floor of which was a
iezo force transducer, enclosed within a light- and sound-
ttenuated chamber. After a 10-min accommodation, a se-
ies of 10 consecutive tones (5 kHz, 110 dB, 200 ms, 15 s in-
erval) as test (eliciting) stimuli were applied. To test PPI
representing sensorimotor gating), the eliciting stimuli were
n a second series (after 15 min rest) preceded by inhibit-
ng (non-startling) pre-pulses (1 kHz, 73 dB, 500 ms, 200 ms
elay between pre-pulse and test pulse; Graham, 1975). A
hole body twitch resulting in more than 50× g force to
he cage floor was accepted as “noise-positive” response, of
hich latency, time to peak and peak amplitude were mea-
ured. Stimulation and data acquisition was controlled by
PC.
.4. Electrophysiology
After finishing all behavioral tests (i.e. after 5 and 10
eeks of Mn administration and at the end of the post-
reatment period), the animals to be recorded (Table 1) were
nesthetized with 1000 mg/kg urethane (Bowman and Rand,
980), and the left hemisphere was exposed by removing the
ony skull. Following a recovery of 30 min minimum, surface
lectrodes were placed on the primary somatosensory, visual
nd auditory cortical focus (Zilles, 1984), and a steel nee-
le electrode was inserted into the hippocampal CA1 region
stereotaxic coordinates: AP −3, L 2, V 2–3; Paxinos and
atson, 1982). Spontaneous electrical activity (electrocor-
icogram) was recorded for 5 min, and subsequently analyzed
or the relative power distribution among the standard fre-
uency bands (delta to gamma; Kandel and Schwartz, 1985).ucrose in PB. Coronal sections were cut on a cryostat micro-
ome at a 50m thickness and collected in phosphate buffered
aline.
Immunohistochemical reactions were performed on free-
oating sections. After abolishing endogenous tissue per-
xidase activity by treatment with 0.6% H2O2 in Tris
uffered saline (TBS; 0.1 M, pH 7.4), the sections were
ncubated in 5% normal goat serum (NGS) in TBS con-
aining 0.1% Triton X-100 for 1 h. Subsequently, tis-
ues samples were incubated in monoclonal anti-GFAP
Sigma, 1:10,000 in TBS containing 0.1% Triton X-100,
% NGS) for 16 h at room temperature. The sections were
horoughly rinsed and exposed to biotinylated goat anti-
ouse IgG (Dianova, 1:300 in TBS containing 5% NGS)
or 1 h. Finally, sections were processed with preformed
omplexes of streptavidin and biotinylated peroxidase and
tained with nickel-enhanced 3,3′-diaminobenzidine as a
hromogen.
The density of GFAP-IR was determined for the hip-
ocampal CA1 stratum radiatum and stratum oriens, and for
he hilus of the dentate gyrus.
The area of GFAP-IR structures was determined by video
maging using an Image Pro Plus 4.0 image analysis soft-
are (Media Cybernetics, Silver Spring, MD, USA). Stained
ections were examined under bright field with an Olympus
icroscope and a 10× objective. Images were recorded with
SONY 950-P CCD camera (Sony Corp., Japan) and digi-
ized. The program expressed the IR positive area as number
f pixels having densities above the threshold. Measurements
ere taken in a blinded fashion from at least 16 sections for
ach animal group and averaged.
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2.6. Tissue manganese level determination
2.6.1. Blood collection, cortex and hippocampus
sampling
Blood and tissue samples were collected in the 5th, 10th
treatment and 12th post-treatment week from 3, 5 and 6
animals per group, respectively (from three rats per group,
blood was also taken in the 0th week). Before the elec-
trophysiological recording, the tail vein was punctured and
blood was taken to heparinized vacutainers of 7.0 ml capac-
ity (Becton–Dickinson, BD367735). All blood samples were
stored at 4 ◦C until analyzed. When the electrophysiological
recording was finished, the animals were sacrificed with an
overdose of Nembutal, the thorax was opened, and the ani-
mals were transcardially perfused with 500 ml saline to re-
move blood from the organs. The brain was removed whole,
without the meninges, and was, under a stereomicroscope,
halved and dissected to isolate the hippocampus. The whole
hippocampus and 0.3 g of the cortex was taken as sample,
kept at −18 ◦C until analyzed.
2.6.2. Manganese level determination
Total manganese content was determined at the accred-
ited laboratory of the National Center for Public Health, Bu-
dapest. The samples were digested in 2 ml concentrated nitric
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ANOVA for the maze results, two-way ANOVA for the open
field and for tissue manganese content results, and one-way
ANOVA for the electrophysiological and morphological re-
sults. Dose was chosen for independent variable, and time
for second independent variable in two-way ANOVA (in the
post-treatment period of the open field tests, time as vari-
able represented the administration of two doses of d-A).
The confidence level was set to p< 0.05 in every case. Post
hoc analysis of group differences after ANOVA was per-
formed by the LSD test; and group comparisons following the
Kruskal–Wallis test were performed by the Mann–Whitney
U-test (also here, p< 0.05). The number of animals giving
“noise-positive response” in the ASR and PPI tests was eval-
uated with the χ2-test. For the statistical analysis, Statistica
for Windows 4.0 software package was used.
3. Results
3.1. Manganese levels
Levels of Mn in various tissues, at the end of the 5th and
10th week of MnCl2 application and the 12th post-treatment
week, are given in Table 2. Compared to the 0th week (pre-
administration) value of 0.0181± 0.003g/g, blood Mn lev-
els increased in a dose- and time-dependent way. In the high
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M ose vs.cid, with 0.5 ml hydrogen peroxide added for cortex and hip-
ocampus. Total manganese in the samples was determined
sing a flameless graphite furnace atomic absorption spec-
rometry.
.7. Data and statistical analysis
The distribution of the data (except the ASR scores) was
hecked for normality by the Kolmogorov–Smirnov test. De-
ending on the distribution, the statistical analyses were car-
ied out by one-way ANOVA or Kruskal–Wallis one-way
able 2
anganese content of the blood, cortex and hippocampus samples taken a
eek of the post-treatment period)
ample Mn (g/g)
Treatment
5th week (n= 3)
lood
Control 0.0314 ± 0.009
14.84 mg/kg 0.0537 ± 0.012
59.36 mg/kg 0.3167 ± 0.136**,##
ortex
Control 0.2167 ± 0.029
14.84 mg/kg 0.2140 ± 0.032
59.36 mg/kg 0.2823 ± 0.031
ippocampus
Control 0.1710 ± 0.012
14.84 mg/kg 0.2607 ± 0.085
59.36 mg/kg 0.2307 ± 0.063
ean±S.D.; n, animals sampled in each group. *, **: p< 0.05, 0.01 high dose group, the increase was significant both in the 5th treat-
ent week (F2,6 = 12.16; high dose versus control, p< 0.01;
igh versus low dose, p< 0.01) and in the 10th treatment
eek (F2,12 = 9.51; high dose versus control, p< 0.01; high
ersus low dose, p< 0.01). By the 12th post-treatment week,
he difference between the blood Mn levels in the control and
reated groups was no more present.
In the brain samples, a build-up of Mn level was also
een in control animals, indicating preferential deposition.
fter 5 weeks MnCl2 treatment, cortical Mn level increased
lightly versus control in the high dose group, and hippocam-
nt times during the experiment (5th and 10th week of treatment, and 12th
Post-treatment
10th week (n= 5) 12th week (n= 6)
0.0118 ± 0.002 0.0138 ± 0.001
0.0164 ± 0.005 0.0167 ± 0.003
0.0364 ± 0.016**,## 0.0165 ± 0.004
0.3134 ± 0.015 0.3130 ± 0.032
0.3220 ± 0.056 0.3095 ± 0.056
0.4420 ± 0.107*,# 0.2872 ± 0.029
0.4604 ± 0.035 0.5897 ± 0.102
0.4680 ± 0.050 0.6022 ± 0.166
0.6813 ± 0.138**,## 0.5662 ± 0.126
control; #, ##: p< 0.05, 0.01 high vs. low dose.
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Fig. 1. The animals’ memory performance during the whole course of the experiment. Abscissa: weeks and phases of the experiment (1st to 10th experimental
weeks, treatment period; 11th to 15th experimental weeks, post-treatment period; see Table 1). Mem 2h, Mem 4h: 2 and 4 h working memory; Mem R 2h, Mem
R 4h: working memory after memory return; (e) indicates the post-treatment period (phase of elimination). Ordinate: weekly averages (mean±S.D.) of the
spatial learning and memory performance in percents in the control and treated groups. , , : p< 0.05, 0.01, 0.001 treated vs. control. #, ##, ###: p< 0.05,
0.01, 0.001 high vs. low dose. Bar pattern: control (); low dose (14.84 mg/kg) ( ); high dose (59.36 mg/kg) ().
pal Mn level, in both treated groups. By the 10th week, the
increase became dose-dependently significant both in the cor-
tex (F2,12 = 5.22; high dose versus control, p< 0.05; high ver-
sus low dose, p< 0.05) and hippocampus (F2,15 = 9.41; high
dose versus control, p< 0.01; high versus low dose, p< 0.01).
These differences also disappeared during the 12 weeks of
post-treatment phase.
3.2. Maze learning and memory
During all phases of the spatial maze learning and memory
test, including the treatment and post-treatment period, both
MnCl2 treated groups showed, compared to control animals,
a decrease in the average memory performance (Fig. 1).
Acquisition (2nd treatment week) was dose-dependently
impaired in the MnCl2 treated rats (F2,15 = 7.51; high dose
versus control, p< 0.01; low, p< 0.05). Reference memory
(4th treatment week) showed in both treated groups a sig-
nificant performance deficit (F2,12 = 24.68; high dose versus
control, p< 0.001; low versus control, p< 0.01; high versus
low dose, p< 0.05). During the 4 h short-term spatial work-
ing memory tests (5th treatment week) the performance of
the treated rats was significantly and dose-dependently lower
than in the controls (F2,9 = 16.85; high dose versus control,
p< 0.001; low versus control, p< 0.05; high versus low dose,
p
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was also significant (p< 0.001). On comparison of the long-
term (9th and 10th week) and short-term (3rd and 5th week)
memory retention it was found that the group receiving low
dose Mn had a better performance in the 9th than in the 3rd
week. All other differences were insignificant.
At the end of the 10th week, Mn administration was fin-
ished. In the 3rd post-treatment week, memory return in the
high dose group was, compared to the 8th treatment week,
greatly improved. In the repeated long-term spatial working
memory test, however, no noteworthy change in any of the
treated groups was seen.
3.3. Open field activity
In the open field activity, MnCl2 treated animals had de-
creased spontaneous activities.
Horizontal activity (running) of the treated animals de-
creased in the 5th and 10th treatment week in a dose- and
time-dependent manner versus untreated (or versus 0th week)
controls (Fig. 2A; F4,72 = 11.04; 5th week: both doses ver-
sus control, p< 0.01; 10th week: both doses versus control,
p< 0.05). The interaction of dose and treatment time was not
significant (F4,72 = 2.17; n.s.).
Decrease of the local activity (consisting predominantly
of grooming; Fig. 2B) became significant by the 10th week
(
o
r
t
p
n< 0.05). After a 2 weeks rest period, the control and low
ose group both showed a memory return to the level seen on
he 2nd week but the level reached by the high dose animals
as markedly less. In the long-term spatial working mem-
ry test (9th treatment week), both MnCl2 treated groups
howed a further significant memory deficit versus control
F2,12 = 26.14; p< 0.001) and the high versus low differenceF4,72 = 3.18; both doses versus control, p< 0.01). Interaction
f doses and treatment times: F4,72 = 1.98; n.s.
Vertical activity (the number of rearings; Fig. 2C) was
educed in a dose- and time-dependent manner versus con-
rols by the 5th week (F4,72 = 7.19; both doses versus control,
< 0.001; interaction: F4,72 = 2.17; n.s.). In the 10th week,
ear-control levels of vertical activity was seen.
804 T. Veze´r et al. / Environmental Toxicology and Pharmacology 19 (2005) 797–810
Fig. 2. Open field performance (A) horizontal activity [running]; (B) local
activity [predominantly grooming]; (C) vertical activity [rearing] in different
phases of the experiment in control and treated rats. Abscissa: weeks of the
experiment: 0 (pre-treatment week), 5, 10 (5th and 10th treatment week),
17, 18, 20 (7th, 8th and 10th post-treatment week). Ordinate: (A) length run,
cm; (B) count, local activity; (C) count, rearing. Numerical performance
value (mean±S.D.), note different scales and units. , , : p< 0.05,
0.01, 0.001 vs. control. Bar pattern as in Fig. 1.
After 7 weeks without treatment the difference between
the control and treated groups was minimal in all three forms
of activity. These records were used as controls versus those
taken in the 8th and 10th post-treatment week (18th and 20th
week of the experiment), when the effect of two doses of d-A
on the open field activity of the control and high- and low-
dose MnCl2 treated rats was studied (Fig. 2A–C, columns for
week 17 and later). In the 8th post-treatment week, 0.5 mg/kg
d-A was given to the rats i.p., which caused no significant al-
teration in the rearing, grooming and horizontal activity of
both treated groups, compared either to the untreated control
group or to the data of the same group before d-A adminis-
tration.
Allowing 2 weeks for d-A to disappear, this test was
repeated on the 10th post-treatment week with a higher
dose (1.5 mg/kg). Here, local activity (Fig. 2B) decreased
in both treated groups (F2,12 = 5.42; low dose versus con-
trol, p< 0.01; high dose, n.s.). Horizontal activity (Fig. 2A)
showed an increasing trend in both groups versus control
but the effect was significant only in the low dose group
(F2,12 = 4.15; p< 0.05). The high dose group also showed
clearly (albeit not significantly) increased vertical activity
after 1.5 mg/kg d-A (Fig. 2C).
In the horizontal activity, comparison of the data of
the 7th, 8th and 10th post-treatment week revealed a sig-
nificant effect of the MnCl2 dose (F4,36 = 3.43, p< 0.05)
and of d-A administration (F4,36 = 51.05, p< 0.001). In the
local (grooming) activity, comparison of the data of the
same post-treatment weeks revealed a significant effect of
MnCl2 dose (F4,36 = 5.69, p< 0.01) and of d-A administra-
tion (F4,36 = 20.63, p< 0.001).
3.4. Acoustic startle response and pre-pulse inhibition
In the 10th treatment week, the effect of Mn on the
number (Fig. 3) and measured parameters (onset latency,
peak time, peak amplitude; Table 3) of the “noise positive”
acoustic startle responses (defined in Section 2.3.4) was be-
low significance. Mn dose-dependently reduced the num-
ber of acoustic responses given on 10 consecutive stimuli
(Fig. 3A; χ2 = 16.63, p< 0.01). The effect of the pre-pulse
inhibition—indicating sensorimotor gating—was strong in
the control group, but in both treated groups it was changed
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to facilitation (i.e. more responses than without pre-pulse,
2
= 22.98, p< 0.01; Fig. 3B versus A). In the 7th post-
reatment week, the number of ASR responses in each of the
roups was not significantly different from the values in the
0th treatment week (Fig. 3C), the reaction of the treated rats
as again significantly different from the controls (χ2 = 9.75,
< 0.05). Now, the pre-pulses exerted their inhibiting action
oth in the treated and control groups making the between-
roup differences insignificant (Fig. 3D; χ2 = 0.55, p> 0.05).
The alterations in the measurable parameters of the ASR
f the control and Mn-treated animals in the 10th treatment
nd 7th post-treatment week were moderate. In the 10th treat-
ent week (Table 3A), onset latency increased significantly
n both treated groups versus control (F2,24 = 4.06; p< 0.05
or both groups versus control). Peak amplitude decreased
n the treated groups but the change was not significant and
as stronger in the low than in the high dose group. Pre-
ulse inhibition in the treated groups was paradox also on
hese parameters: the startle responses became faster and
tronger (F2,23 = 10.01; low dose versus control, p< 0.001;
igh, p< 0.01). After 7 weeks of treatment (Table 3B) most
f the effects were still present but the paradoxical effect of
he pre-pulse was no more seen. ASR latency: F2,14 = 8.20;
igh dose versus control, p< 0.01; high versus low dose,
< 0.05. ASR peak time:F2,14 = 11.58; high dose versus con-
rol, p< 0.001; high versus low dose, p< 0.01.
.5. Electrophysiological parameters
In the spontaneous cortical and hippocampal activity,
here were minor, non-significant changes in the power
T. Veze´r et al. / Environmental Toxicology and Pharmacology 19 (2005) 797–810 805
Fig. 3. Number of positive startle responses given on 110 dB acoustic stimulus, without (A, C) and with (B, D) pre-pulse inhibition, at the end of the treatment
period (10th week, top) and in the 7th week of the post-treatment period (bottom), in control and treated (low dose, 14.84 mg/kg; high dose, 59.36 mg/kg) rats.
The bars show the distribution of rats (n= 12 per group in the 10th treatment week, and n= 6 per group in the 7th post-treatment week) according to the number
of responses: (0–4 (); 5–7 ( ); 8–10 ()) given on 10 consecutive stimuli.
distribution over the frequency range on Mn application
(Fig. 4A–D). The general trend was increase in the theta
and decrease in the beta2 and gamma bands but the dose-
dependence was not clear. In the 12th post-treatment week
(Fig. 4E–H), the changes of the spontaneous activity in
the cortex disappeared but the decrease in the beta2 and
gamma band of the hippocampal activity became more
expressed.
In the sensory EPs, the general effect after 10 weeks Mn
administration (Fig. 5A–C) was a lengthening of the latency
(significant in the somatosensory and visual EP, p< 0.05).
The alteration of the duration was mostly negligible. After 12
Table 3
Measured parameters of the acoustic startle response in control and treated animals after 10 weeks Mn administration (A) and after subsequent 7 weeks
elimination (B)
Control MnCl2
14.84 mg/kg 59.36 mg/kg
(A) Startle response in the 10th week of the treatment period
Acoustic startle response
Onset latency (ms) 19.384 ± 1.8209 (n= 9) 22.095 ± 1.5013* (n= 9) 21.694 ± 2.9442* (n= 9)
Peak time (ms) 26.709 ± 1.5104 (n= 9) 27.491 ± 2.0387 (n= 9) 27.127 ± 1.8735 (n= 9)
Peak amplitude (g) 285.794 ± 150.9 (n= 9) 153.076 ± 71.1477 (n= 9) 252.200 ± 154.15 (n= 9)
ASR with pre-pulse inhibition
Onset latency (ms) 23.221 ± 1.8558 (n= 8) 19.520 ± 1.7919*** (n= 9) 19.837 ± 1.9564** (n= 9)
Peak time (ms) 26.711 ± 1.6376 (n= 8) 25.812 ± 1.0045 (n= 9) 25.911 ± 1.4715 (n= 9)
Peak amplitude (g) 128.130 ± 125.96 (n= 8) 203.648 ± 72.635 (n= 9) 185.696 ± 100.45 (n= 9)
(B) Startle response in the 7th week of the post-treatment period
Acoustic startle response
Onset latency (ms) 19.182 ± 1.3883 (n= 6) 20.800 ± 1.3509 (n= 6) 23.826 ± 2.8222**,# (n= 6)
Peak time (ms) 25.527 ± 1.1923 (n= 6) 27.060 ± 0.9581 (n= 6) 30.56 ± 2.724***,## (n= 6)
O e cours
nPeak amplitude (g) 197.030 ± 64.9463 (n= 6)
ASR with pre-pulse inhibition
Onset latency (ms) 21.951 ± 3.708 (n= 5)
Peak time (ms) 28.207 ± 3.6450 (n= 5)
Peak amplitude (g) 214.761 ± 120.709 (n= 5)
nset latency, peak time and peak amplitude were determined from the tim
, animals investigated in each group. *, **, ***: p< 0.05, 0.01, 0.001 vs. control; #203.494 ± 57.2813 (n= 6) 188.680 ± 100.367 (n= 6)
22.536 ± 1.3707 (n= 5) 25.250 ± 4.3373 (n= 5)
28.260 ± 0.7829 (n= 5) 29.800 ± 2.7055 (n= 5)
155.970 ± 113.5942 (n= 5) 90.567 ± 55.0914 (n= 5)
e of the force, exerted by the startled rat on the cage bottom. Mean±S.D.;
, ##: p< 0.05, 0.01 high vs. low dose.
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Fig. 4. Power spectrum of the rats’ spontaneous cortical and hippocampal electrical activity, in the 10th treatment week (left column: (A) somatosensory; (B)
visual; (C) auditory cortex; (D) hippocampal CA1) and in the 12th post-treatment week (right column: (E) somatosensory; (F) visual; (G) acoustic cortex; (H)
hippocampal CA1). Abscissa: ECoG frequency bands. Ordinate: relative power, mean±S.D. Bar pattern: control ( ); low dose ( ); high dose ( ).
weeks without Mn administration (Fig. 5D–F), some of the
effects disappeared (on the somatosensory EP) while others
remained (on the visual EP).
3.6. Immunhistochemistry
In the density of GFAP immunoreactive structures in the
hippocampal CA1 region of the investigated rats, no differ-
ences were seen between the control animals and those treated
with low and high dose of MnCl2. However, in the hilar part of
the dentate gyrus, there was an increase of GFAP-IR density
at both concentrations of manganese treatment (Fig. 6).
4. Discussion
Subchronic administration of MnCl2 to the rats in this
study resulted in marked internal exposure (shown by the Mn
levels in the cortex and hippocampus; Table 2). Mn levels in
the control rats’ brains, originating from the background Mn
present in standard food and drinking water, were similar to
that described earlier by Rehnberg et al. (1982).
From the gastrointestinal tract, absorption of ionic Mn is
low (<10%) and self-limited in the rats (Davis et al., 1992).
Once absorbed, Mn is bound to plasma proteins and is read-
ily taken up into the CNS, as a free ion or in transferrin-
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Fig. 5. Latency and duration of the sensory evoked potentials in the 10th treatment week (left column: (A) somatosensory; (B) visual; (C) auditory EP) and in
the 12th post-treatment week (right column: (D) somatosensory; (E) visual; (F) auditory EP). Ordinate: latency (lat.) and duration (dur.) in ms, mean±S.D. ,
: p< 0.05, 0.01 treated vs. control. Bar pattern as in Fig. 4.
Fig. 6. Presence of GFAP-immunoreactive elements in different parts of the
hippocampus (stratum radiatum and stratum oriens of CA1, and hilus of
the dentate gyrus) in control and treated rats in the 10th week of treatment.
Ordinate: GFAP positivity in percent of the total area (mean±S.D., on the
basis of numerous sections from two animals per group). : p< 0.05 treated
vs. control. Bar pattern as in Fig. 4.
bound form (Aschner and Gannon, 1994). There is a slow
shift of Mn from the parenchymal organs to the CNS where
Mn will be deposited. Elimination of Mn from the CNS, first
of all from the cerebrum, is much slower than from the whole
body (Cotzias et al., 1968). Following a shorter exposure by
doses similar to what was given in our work, Mn levels in
the typically affected parts of the brain (striatum, hypothala-
mus, nucleus accumbens) were not paralleled by the levels of
transmitters and their metabolites (Kontur and Fechter, 1988);
indicating that the brain has some capacity of compensating
the adverse effects of Mn.
Among the cell types constituting the brain tissue, Mn is
accumulated in astrocytes, crucial in neutralizing glutamate
released in the glutamatergic (e.g. thalamocortical) synapses.
This process was inhibited in astrocytes exposed to elevated
Mn2+ (Normandin and Hazell, 2002), resulting first in over-
stimulation then in desensitization or down-regulation of glu-
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tamate receptors, possibly leading to the latency lengthening
of the cortical EP seen by us. Alterations of evoked responses
in Mn-exposed humans have also been described together
with changes in the EEG. The latter has a well-known activat-
ing cholinergic modulation (Metherate et al., 1992) and if the
elevated Mn level in the brain reduces the activity of choline
acetyltransferase (Lai et al., 1981), the ascending activating
input can be diminished. The slight changes of cortical and
hippocampal activity observed in our study were in line with
the above.
The hippocampal formation (with retrosplenial cortex and
dorsal striatum), is a preferential site of Mn accumulation, and
is an important neural axis responsible for spatial memory and
reward-based learning. In our experiments, the performance
in acquisition, short-term retention tasks and long-term spa-
tial working memory—a stable and reliable phenomenon in
rats—was significantly decreased in the MnCl2-administered
animals in the 10th treatment week, indicating functional
damage. A possible morphological counterpart, gliotic de-
generation, was in fact seen in the dentate gyrus, in both
treated groups in the 10th week. The dentate gyrus and CA1
areas of the hippocampus, are integral neural substrates in
the acquisition of new information, hence important loci for
spatial learning and working memory processes (Eyre et al.,
2003). In our work, elevated hippocampal Mn level and al-
t
e
e
a
m
S
p
h
t
m
c
a
r
s
(
F
c
c
h
i
m
2
f
h
t
a
i
i
i
long-term spatial memory test, significantly decreased per-
formance was still seen in the both treated groups. In the OF
activity of the control and treated rats, no more difference was
detected, but by injecting 1.5 mg/kg d-A, the residual effects
of Mn—substantial increase of the horizontal and vertical,
and decrease of the local activity—were revealed (Fig. 2).
In the horizontal and local activity, the effect was stronger
in the low-dose group, possibly due to the dose-dependent
elimination mentioned above.
In 7th post-treatment week, the magnitude of the ASR
was still diminished but the reduction of pre-pulse inhibition
was no more seen. The alterations of the spontaneous cortical
activity had a similar time course indicating that the effect of
Mn on the cholinergic system was probably responsible for
both.
5. Conclusion
The main points of conclusion drawn from the above re-
sults are as given below.
Oral MnCl2 treatment, 14.84 and 59.36 mg/kg b.w., for
10 weeks brought about, primarily in the high-dose group,
an increase in first the blood, then cortex and hippocampus
Mn levels.
t
o
w
d
i
o
t
t
t
r
a
i
t
f
c
p
t
fi
i
t
c
o
k
e
i
c
e
tered frequency spectrum of the hippocampal spontaneous
lectrical activity was seen at the end of the 10th week of Mn
xposure.
The rats’ extrapyramidal motor control (Bonilla, 1984),
nd the sensorimotor integration, is dependent on the
esolimbic and nigrostrial dopaminergic system (Fink and
mith, 1980), both known to show dysfunction on Mn ap-
lication. In our experiments, decrease of the spontaneous
orizontal and vertical activity in the open field was seen in
he 5th, and of the local activity in the 10th, week of treat-
ent. The number of “noise-positive” ASR responses de-
reased, and their onset latency increased, in the Mn-treated
nimals in the 10th week. Sensorimotor gating was, however,
educed in both Mn-treated groups at the end of treatment,
o that the pre-pulse inhibition was inverted to facilitation
shown by the number of responses and by the peak time, see
ig. 3 and Table 3). In the cholinergic neurons of the pedun-
ulopontine tegmental nucleus, an important part of the PPI
ircuit (Swerdlow and Geyer, 1993) neurotoxic lesion by Mn
as been described (Tomas-Camardiel et al., 2002), result-
ng in significantly reduced PPI without affecting the startle
agnitude in the absence of a pre-pulse (Jones and Shannon,
000).
During the post-treatment period, elimination of the Mn
rom the cortex and hippocampus was seen. The cortical and
ippocampal Mn levels were falling more in the high dose
han in the low dose group during the post-treatment period,
nd some effects of Mn showed inverted dose dependence
n this period, which may be due to the dose-dependently
ncreasing elimination of Mn (Mena et al., 1967). The major-
ty of behavioral effects, however, remained. In the repeatedDuring the treatment period, altered PPI and cortical spon-
aneous activity in the treated rats suggested the involvement
f brainstem cholinergic systems (pre-pulse inhibition path-
ay and ascending cortical activation) due to Mn-induced
amage. The alterations in maze learning, open field activ-
ty and ASR magnitude suggested the decrease of certain
ther neurotransmitter levels (e.g. DA or Glu) in the cen-
ers responsible for these behavioral functions, pointing to
he involvement of the glutamatergic auditory pathway and
he nigrostriatal dopaminergic system, and possibly to neu-
opathological changes in some components of the neural
xis for behavior (e.g. hippocampal formation). The changes
n the cortical EPs also indicated the involvement of the glu-
amatergic afferent pathways. In the treated rats, gliosis was
ound in the hilar part of the dentate gyrus compared to the
ontrols.
In the post-treatment period, Mn levels in all tissue sam-
les from the previously treated animals returned to the con-
rol. The alterations of the long-term spatial memory, the open
eld activity and the ASR reaction, however, remained. This
ndicated a long-lasting effect of Mn on these functions, al-
hough the dose–effect relationship elimination was in some
ases anomalous.
By applying a complex set of methods, it was possible to
btain new data for a better-based relationship between the
nown effects of Mn at neuronal level and the behavioral and
lectrophysiological outcomes of MnCl2 exposure observed
n our study and described in the literature. Taking into ac-
ount that some of the effects proved to outlast the period of
xposure, and the importance of the probably involved sys-
ems in the higher-order nervous functions of humans, the
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neurotoxic risk of environmental and/or occupational MnCl2
exposure seems to deserve ongoing attention.
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